HIGHLIGHTS
- who: February and colleagues from the University of Calgary, Canada have published the article: Trained immunity in monocyte/ macrophage: Novel mechanism of phytochemicals in the treatment of atherosclerotic cardiovascular disease, in the Journal: (JOURNAL)
- what: This study demonstrated that in contrast to macrophages activated with LPS alone, those exposed to oxPAPC and LPS together had a metabolic change (Di Gioia et_al, 2020). The authors examine some significant natural products that may target monocyte/macrophage and trained immunity in AS in this section.
- how: This review describes the aforementioned mechanisms in detail. The authors . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.